TAEST16001 NY-ESO-1 TCR

NY-ESO-1–specific T-cell receptor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAEST16001 NY-ESO-1 TCR, covering 2019-01-17 to 2019-01-17. Get the full timeline:

Most recent: Clinical Trial Update: NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC [Phase 1]